{"transactions":[{"id":4614472,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-10T19:34:32.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":1911,"price":1.1584,"value":2213.7024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":206580,"source":{"system":"sec-edgar","filing":"0001193125-26-387786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995657/000119312526387786/ownership.xml","form_type":"4"}},{"id":742572,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T15:23:47.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":2884,"price":1.299,"value":3746.316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":208491,"source":{"system":"sec-edgar","filing":"0001193125-26-265335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526265335/ownership.xml","form_type":"4"}},{"id":815393,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T17:40:12.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":144000,"derivative":{"exercise_price":1.34,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001193125-26-141867","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526141867/ownership.xml","form_type":"4"}},{"id":815392,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T17:40:12.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":211375,"source":{"system":"sec-edgar","filing":"0001193125-26-141867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526141867/ownership.xml","form_type":"4"}},{"id":852925,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-09T21:16:44.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":1581,"price":1.6,"value":2529.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":187375,"source":{"system":"sec-edgar","filing":"0001193125-26-098824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526098824/ownership.xml","form_type":"4"}},{"id":977260,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-08T18:49:50.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":1576,"price":1.7719,"value":2792.5144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":188956,"source":{"system":"sec-edgar","filing":"0001193125-25-310953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312525310953/ownership.xml","form_type":"4"}},{"id":984782,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-02T00:32:32.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":1.6,"value":192000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":190532,"source":{"system":"sec-edgar","filing":"0001193125-25-304218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312525304218/ownership.xml","form_type":"4"}},{"id":984781,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-02T00:32:32.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":1576,"price":1.81,"value":2852.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units (\"RSUs\") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":70532,"source":{"system":"sec-edgar","filing":"0001193125-25-304218","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312525304218/ownership.xml","form_type":"4"}},{"id":1117237,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-09T22:54:26.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":1576,"price":1.75,"value":2758.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."}],"balance_after":72108,"source":{"system":"sec-edgar","filing":"0000950170-25-083949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025083949/ownership.xml","form_type":"4"}},{"id":1178607,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T15:58:31.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":84000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0000950170-25-050103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025050103/ownership.xml","form_type":"4"}},{"id":1178606,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-03T15:58:31.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":73684,"source":{"system":"sec-edgar","filing":"0000950170-25-050103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025050103/ownership.xml","form_type":"4"}},{"id":1216750,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-07T21:36:31.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":1808,"price":1.8748,"value":3389.6384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.85 to $1.90, inclusive. The reporting person undertakes to provide to Metagenomi, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":59684,"source":{"system":"sec-edgar","filing":"0000950170-25-035565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025035565/ownership.xml","form_type":"4"}},{"id":1340059,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:24:30.000Z","date":"2024-12-05","kind":"sale","planned":false,"acquired":false,"shares":1559,"price":1.86,"value":2899.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."}],"balance_after":61492,"source":{"system":"sec-edgar","filing":"0000950170-24-134124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017024134124/ownership.xml","form_type":"4"}},{"id":1412490,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-06T21:14:54.000Z","date":"2024-09-05","kind":"sale","planned":false,"acquired":false,"shares":6265,"price":2.88,"value":18043.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions ranging from $2.80 to $2.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shars sold at each price."}],"balance_after":63051,"source":{"system":"sec-edgar","filing":"0000950170-24-104439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017024104439/ownership.xml","form_type":"4"}},{"id":1548418,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:52:11.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":291450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on September 18, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":291450,"derivative":{"exercise_price":10.82,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":291450},"source":{"system":"sec-edgar","filing":"0000950170-24-041537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017024041537/ownership.xml","form_type":"4"}},{"id":1548417,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":39530,"kind":"person","name":"Wapnick Pamela","position":1,"cik":"0001995657","reported_name":"Wapnick Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-04T00:52:11.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":69316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on September 5, 2024, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":69316,"source":{"system":"sec-edgar","filing":"0000950170-24-041537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017024041537/ownership.xml","form_type":"4"}}]}